![]() |
|
|
Forward to a colleague |
||
Access Full Stories German chemicals firm BASF has announced a major price hike across its range of pharmaceutical excipients, upping price tags by as much as 9 per cent... Read AstraZeneca axes packaging plant AstraZeneca's axe has made its latest appearance in South Africa, with the sale of a packaging plant and the formation of an outsourcing deal with its new owners... Read $60m expansion for mystery pharma Swedish construction firm Skanska today announced that it has been awarded a multi-million dollar contract to expand a pharmaceutical facility in the US, though the company is keeping the identity of its client... Read WHO talks on research strategy for developing world diseases stall Talks between the drug industry and World Health Organization (WHO) member states over how narrow the health gap between rich and poor countries have stalled... Read Merck HIV vaccine failure puts cold virus on trial Merck & Co's failed HIV vaccine may actually increase the risk of infection and the latest data raises questions over whether the cold virus used as a delivery technique was at fault... Read |
||||||||||||||
All News Headlines for: November | October | September |
||||||||||||||
![]() Advanced Chiral Chromatography DAICEL announce the launch of CHIRALPAK® IC. The combination of CHIRALPAK® IA, IB and now IC provides a screening set of column with exceptionally high success rates. The chiral separation of > 99% of all small molecules is attained using just 3 columns and four... Click Here | ||||||||||||||
|
Related Industry News New drug safety model unveiled as Merck shells out for Vioxx A new 3D model of the human liver that even has its own blood supply could pump new life into drug safety tests by predicting problems earlier and cut down on animal experiments... Read Tripos lands Schering-Plough deal Tripos Discovery Research (TDR) has risen from the ashes surrounding the liquidation of its previous owners Tripos, Inc. to land a 'library enrichment' deal with Schering-Plough... Read China CRO attracts $30m US investment China's second largest contract research organisation (CRO) ShangPharma has attracted $30m (€21m) from US private investment firm TPG as the Asian pharma market continues to simmer... Read Aveo strategy ups chances of cancer drug success US-based Aveo Biopharmaceuticals is hoping to prove its R&D strategy can buck high industry failure rates when trying to design new cancer drugs and it seems to be working after its lead drug has passed a first-in-man... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||